- Home
- KALV vs TRNS Comparison
KALV vs TRNS Comparison
Compare KALV & TRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KALV
- TRNS
- Stock Information
- Founded
- KALV N/A
- TRNS 1964
- Country
- KALV United States
- TRNS United States
- Employees
- KALV N/A
- TRNS N/A
- Industry
- KALV Biotechnology: Pharmaceutical Preparations
- TRNS Electrical Products
- Sector
- KALV Health Care
- TRNS Industrials
- Exchange
- KALV Nasdaq
- TRNS Nasdaq
- Market Cap
- KALV 637.9M
- TRNS 748.7M
- IPO Year
- KALV N/A
- TRNS N/A
- Fundamental
- Price
- KALV $12.34
- TRNS $78.94
- Analyst Decision
- KALV Strong Buy
- TRNS Buy
- Analyst Count
- KALV 9
- TRNS 4
- Target Price
- KALV $26.29
- TRNS $108.67
- AVG Volume (30 Days)
- KALV 1.0M
- TRNS 85.6K
- Earning Date
- KALV 09-04-2025
- TRNS 08-06-2025
- Dividend Yield
- KALV N/A
- TRNS N/A
- EPS Growth
- KALV N/A
- TRNS N/A
- EPS
- KALV N/A
- TRNS 1.44
- Revenue
- KALV N/A
- TRNS $288,138,000.00
- Revenue This Year
- KALV N/A
- TRNS $10.85
- Revenue Next Year
- KALV $192.67
- TRNS $6.52
- P/E Ratio
- KALV N/A
- TRNS $54.96
- Revenue Growth
- KALV N/A
- TRNS 8.49
- 52 Week Low
- KALV $7.30
- TRNS $67.56
- 52 Week High
- KALV $16.32
- TRNS $133.72
- Technical
- Relative Strength Index (RSI)
- KALV 36.00
- TRNS 47.93
- Support Level
- KALV $12.19
- TRNS $71.95
- Resistance Level
- KALV $14.35
- TRNS $85.93
- Average True Range (ATR)
- KALV 0.61
- TRNS 3.83
- MACD
- KALV -0.30
- TRNS 0.04
- Stochastic Oscillator
- KALV 5.26
- TRNS 56.01
About KALV KalVista Pharmaceuticals Inc.
KalVista Pharmaceuticals Inc is a pharmaceutical company developing and delivering oral therapies for individuals affected by rare diseases with unmet needs. The company applies its knowledge in the kallikrein-kinin system (KKS) and oral drug discovery to develop small-molecule protease inhibitor medicines to address the needs of patients with diseases driven by plasma kallikrein and Factor XIIa. Its FDA-approved product EKTERLY (sebetralstat) is a novel, orally delivered, small-molecule plasma kallikrein inhibitor for the treatment of acute attacks of hereditary angioedema (HAE) in adult and pediatric patients aged twelve years and older.
About TRNS Transcat Inc.
Transcat Inc is involved in providing calibration and laboratory instrument services and distribution of test, measurement, and control instrumentation. Its product and services portfolio consists of calibration instruments, dimensional measuring tools, Electrical test instruments, pressure measurement, etc. The firm has Service and Distribution operating segments. It derives the majority of its revenues from the Service segment. The firm promotes and sells its products under brand names such as Estech, FLIR, Fluke, Keysight, and Megger among others. It serves to pharmaceutical, industrial manufacturing, energy, and chemical process industries.